AnPac Bio-Medical Science

$5.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-1.33%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ANPC and other stocks, options, and ETFs commission-free!

About ANPC

AnPac Bio-Medical Science Co., Ltd. American Depositary Shares, also called AnPac Bio-Medical Science, is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. The listed name for ANPC is AnPac Bio-Medical Science Co., Ltd. American Depositary Shares.

CEO
Chang Yu
Employees
111
Headquarters
Lishui, Shanghai
Founded
2010
Market Cap
64.65M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
93.22K
High Today
$6.05
Low Today
$5.91
Open Price
$5.93
Volume
23.55K
52 Week High
$12.18
52 Week Low
$3.15

Collections

ANPC Earnings

Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 20, Pre-Market

You May Also Like

PRVL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure